• Home
  • NEW DAY MEDICINE
  • 3 (41) 2022
  • 50 -3 (41) 2022 — Fayzullaeva Nigora Yakhyaevna Raufov Alisher Anvarovich — PECULIARITIES OF IMMUNOLOGICAL RESPONSE IN PATIENTS WITH OVERCROSSED BRONCHIAL ASTHMA AND COPD

50 -3 (41) 2022 — Fayzullaeva Nigora Yakhyaevna Raufov Alisher Anvarovich — PECULIARITIES OF IMMUNOLOGICAL RESPONSE IN PATIENTS WITH OVERCROSSED BRONCHIAL ASTHMA AND COPD

PECULIARITIES OF IMMUNOLOGICAL RESPONSE IN PATIENTS WITH OVERCROSSED BRONCHIAL ASTHMA AND COPD

Fayzullaeva Nigora Yakhyaevna Institute of Immunology and Human Genomics

Raufov Alisher Anvarovich Bukhara State Medical Institute, Tashkent, Bukhara

Resume

This article discusses the issues of immunological status in patients with asthma, COPD and ACO. A correlation analysis of 10 clinical and immunological parameters was carried out, on the basis of which (IL-8 va IFNy) an index for the prognosis of the course of the disease of bronchial asthma and COPD overlap was developed, which makes it possible to predict the course of the disease and the choice of adequate therapy.

Keywords: BA, COPD, ACO, cytokines, IgE, correlation analysis.

First page

241

Last page

248

For citation: Fayzullaeva Nigora Yakhyaevna Raufov Alisher Anvarovich PECULIARITIES OF IMMUNOLOGICAL RESPONSE IN PATIENTS WITH OVERCROSSED BRONCHIAL ASTHMA AND COPD //New Day in Medicine 3(41)2022 241-248 https://clck.ru/frXTm

LIST OF REFERENCES:

  1. Lobanova E.G., Kalinina E.P. Features of the regulation of the immune response in patients with comorbid course of chronic obstructive pulmonary disease and bronchial asthma. //Pulmonology. 2014; 6:5-10.
  2. Trushina E.Yu., Kostina E.M. The role of cytokines IL-4, IL-6, IL-8, IL-10 in the immunopathogenesis of chronic obstructive pulmonary disease. //Medical immunology. 2019, Vol. 21, No. 1, pp. 89-98
  3. Kalinina E.P., Lobanova E.G. Features of the cytokine profile in patients with chronic obstructive pulmonary disease. //Medical immunology. 2012; 14(6): 501–506.
  4. Dugarova I.D., Anaev E.Kh., Chuchalin A.G. On the role of cytokines in bronchial asthma. //Pulmonology. 2010; 4:96-102.
  5. Antonovich Zh.V., Tsarev V.P., Goncharova N.V. Natural regulatory T cells and cytokines in patients with bronchial asthma in different periods of the disease. //Immunopathology, allergology, infectology. 2012; 4:35–44.
  6. Kirillova N.A., Deev I.A., Kremer E.E. Regulatory T cell subpopulations in bronchial asthma and heterogeneous phenotypes of chronic obstructive pulmonary disease. //Bulletin of Siberian Medicine. 2011; 1:48–54.
  7. Kalinina E.P., Lobanova E.G. Diagnostic criterion for the progression of chronic obstructive pulmonary disease. //Bulletin SO RAMS. 2010; 1 (141): 5–8.
  8. Barnes PJ Mechanisms in COPD: Differences from asthma. Chest. 2000; 117:10–14.
  9. Global Strategy for the Diagnosis, Treatment and Prevention of Chronic Obstructive Pulmonary Disease (2011 Revision). Per. from English. ed. A.S. Belevsky. Moscow: Russian Respiratory Society; 2012
  10. Abdurakhmanova I.S., Nikulicheva V.I., Vagapova D.R., Enikeev O.A. The nature of the expression of pro-inflammatory cytokines in patients with chronic obstructive pulmonary disease // Saratov Journal of Medical Scientific Research, 2010. V. 6, No. 2. P. 314-317.
  11. Berezhnaya N.M. Cytokine regulation in pathology: rapid development and inevitable issues // Cytokines and inflammation, 2007. V. 6, No. 2. P. 26-34.
  12. Berezhnaya N.M., Sepiashvili R.I. Interleukins in the pathogenesis of atopic allergic diseases // Allergology and Immunology, 2014. V. 15, No. 3. P. 169-176.
  13. Blinova T.V., Strakhova L.A., Lavrenyuk N.A., Umnyagina I.A. Cytokine profile of blood serum in chronic obstructive pulmonary disease of professional etiology in the stable phase of the disease and its association with other markers of the inflammatory process // Pulmonology, 2015. V. 25, No. 5. P. 566-573.
  14. Voronina M.S., Shilkina N.P., Vinogradov A.A., Butusova S.V. Interleukins 4, 6, 8 in the pathogenesis of rheumatoid arthritis and its complications // Cytokines and inflammation, 2014. V. 13, No. 1. P. 5-10.
  15. Gereng E.A., Sukhodolo I.V., Pleshko R.I., Ogorodova L.M., Akbasheva O.E., Bukreeva E.B., Dzyuman A.N., Kobyakova O.S., Selivanova P.A., Kremis I.S. Morphological and biochemical markers of inflammatory reactions in the bronchial mucosa in severe bronchial asthma and chronic obstructive pulmonary disease // Bulletin of Siberian Medicine, 2009. No. 3. P. 11-17.
  16. Dolinina L.Yu., Delieva A.N., Kaklyugin A.P., Bogdanova E.O., Galkina O.V., Trofimov V.I. Comparative analysis of the level of pro-inflammatory cytokines in patients with chronic obstructive pulmonary disease depending on the stage of the disease // Archives of Internal Medicine, 2012. No. 1 (3). pp. 64-67.
  17. Efremov A.V., Tuleutaeva R.E., Safronov I.D. The content of pro- and anti-inflammatory cytokines in the blood of patients with chronic obstructive pulmonary disease at different stages of the disease // Medicine and Education in Siberia, 2014. No. 6. Ketlinsky S.A., Simbirtsev A.S. Cytokines. St. Petersburg: Foliant, 2008. 552 p.
  18. Pribylov S.A. Pro-inflammatory cytokines in chronic obstructive pulmonary disease // Bulletin of new medical technologies, 2007. V. 10, No. 3. P. 25-28.
  19. Zhu Z., Homer RJ, Wang Z., Chen Q., Geba GP, Wang J., Zhang Y., Elias JA Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. //J.Clin. Invest., 1999, Vol. 103, pp. 779-788.
  20. Andersén H, Lampela P, Nevanlinna A, Säynäjäkangas O, Keistinen T. High hospital burden in overlap syndrome of asthma and COPD. //Clin Respir J. 2013;7(4):342–346. doi: 10.1111/crj.12013.

file

download